Basic info
Industry
biotechnology research
Sectors
Biotechnology
Consulting
Therapeutics
Manufacturing
Date founded
2021
Funding rounds raised
Total raised
$66M
from 6 investors over 6 rounds
A
Ascend Gene & Cell Therapies raised $66M on May 9, 2023
Investors: Digitalis Ventures, Abingworth, Ajinomoto Sales (Thailand) Co., Ltd, Cathay Health, - and DCVC Bio